Solidarity Trial

Tahapan Penelitian : Rekrut
Sponsor:
Mitra Pelaksana:
RSPI Prof. Sulianti Saroso RSUP H. Adam Malik RSUP Dr. Hasan Sadikin RSUD Dr. Soetomo RS Univ. Udayana RSUP Dr. Kariadi RSUP Dr. Sardjito RSUPN. Dr. Cipto Mangunkusumo RSUD Dr. Moewardi RSUP Sanglah RSUP Prof. Dr. Kandao RSUP Dr. Wahidin Sudirohusodo RSJ Prof. Dr. Soerojo RSUP Dr. M. Djamil RS Univ. Airlangga RS YARSI RSUD Dr. Achmad Mochtar RSUD Dr. Saiful Anwar RSUP Persahabatan RSPAU Dr. Esnawan Antariksa
No Registry
INA-6E2YX0X
Tanggal Input Registry : 01-09-2020

23-04-2020
duration of stay
ventilation
 
Solidarity Trial
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care
Eksperimental
Local standard of care alone, OR local standard of care plus one of • Remdesivir (daily infusion for 10 days) • Chloroquine or hydroxychloroquine (two oral loading doses, then orally twice daily for 10 days) • Lopinavir with Ritonavir (orally twice daily for 14 days) • Lopinavir with Ritonavir (ditto) plus Interferon (daily injection for 6 days).
1000
 

Inclusion Criteria:

consenting adults (age ≥18) hospitalised with definite COVID-19, not already receiving any of the study drugs, without known allergy or contra-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non-study hospital.

Exclusion Criteria:

-
 
LB.02.01/2/KE.237/2020
tidak berlaku
. R-RG.01.06.3.32.321.04.20.302
Solidarity Trial
Retna 0811987432